Search research articles
Contact Us
Filters
Showing results (1-10 of 35) with videos related to
Page
of 4
Sort By:
The Journal of Pathology
|
October 16, 2020
Professor Dennis H Wright: an appreciation
Margaret Ashton-Key, Adrian Bateman
The New England Journal of Medicine
|
May 24, 2023
BCL2 Inhibition in Refractory Hairy-Cell Leukemia
Francesco Forconi, Margaret Ashton-Key, Nicola Meakin
International Journal of Surgery Case Reports
|
April 5, 2017
Recurrent constrictive pericarditis associated with seropositive rheumatoid arthritis: A case report
Daniela Votano, Geoffrey M Tsang, Margaret Ashton-Key, et al.
Journal of Clinical Pathology
|
April 30, 2026
TCRbeta1/TCRbeta2 (TRBC1/TRBC2) antibody pair for determining T-cell monotypia as a surrogate for clonality in formalin-fixed paraffin-embedded material
Anuradha Kaistha, Jinlong J Situ, Shelley Evans, et al.
Blood
|
December 20, 2008
Primary central nervous system lymphoma: tumor-related clones exist in the blood and bone marrow with evidence for separate development
Katy J McCann, Margaret Ashton-Key, Kellyann Smith, et al.
British Journal of Haematology
|
January 26, 2008
Intestinal strictures: a new complication of treatment for primary gastrointestinal diffuse large B-cell lymphoma
Jonathan P Kerr, Mandy Turner, Margaret Ashton-Key, et al.
British Journal of Haematology
|
August 22, 2014
Expression of the inhibitory Fc gamma receptor IIB (FCGR2B, CD32B) on follicular lymphoma cells lowers the response rate to rituximab monotherapy (SAKK 35/98)
Chern Siang Lee, Margaret Ashton-Key, Sergio Cogliatti, et al.
Oncotarget
|
February 3, 2017
Angioimmunoblastic T cell lymphoma: novel molecular insights by mutation profiling
Ming Wang, Shaowei Zhang, Shih-Sung Chuang, et al.
Frontiers in Immunology
|
February 25, 2021
Developing a 3D B Cell Lymphoma Culture System to Model Antibody Therapy
Russell Foxall, Priyanka Narang, Bridget Glaysher, et al.
Exploration of Targeted Anti-Tumor Therapy
|
September 16, 2024
The genomic and molecular landscape of splenic marginal zone lymphoma, biological and clinical implications
Amatta Mirandari, Helen Parker, Margaret Ashton-Key, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 35) with videos related to
Sort By:
Page
of 4
The Journal of Pathology
|
October 16, 2020
Professor Dennis H Wright: an appreciation
Margaret Ashton-Key, Adrian Bateman
The New England Journal of Medicine
|
May 24, 2023
BCL2 Inhibition in Refractory Hairy-Cell Leukemia
Francesco Forconi, Margaret Ashton-Key, Nicola Meakin
International Journal of Surgery Case Reports
|
April 5, 2017
Recurrent constrictive pericarditis associated with seropositive rheumatoid arthritis: A case report
Daniela Votano, Geoffrey M Tsang, Margaret Ashton-Key, et al.
Journal of Clinical Pathology
|
April 30, 2026
TCRbeta1/TCRbeta2 (TRBC1/TRBC2) antibody pair for determining T-cell monotypia as a surrogate for clonality in formalin-fixed paraffin-embedded material
Anuradha Kaistha, Jinlong J Situ, Shelley Evans, et al.
Blood
|
December 20, 2008
Primary central nervous system lymphoma: tumor-related clones exist in the blood and bone marrow with evidence for separate development
Katy J McCann, Margaret Ashton-Key, Kellyann Smith, et al.
British Journal of Haematology
|
January 26, 2008
Intestinal strictures: a new complication of treatment for primary gastrointestinal diffuse large B-cell lymphoma
Jonathan P Kerr, Mandy Turner, Margaret Ashton-Key, et al.
British Journal of Haematology
|
August 22, 2014
Expression of the inhibitory Fc gamma receptor IIB (FCGR2B, CD32B) on follicular lymphoma cells lowers the response rate to rituximab monotherapy (SAKK 35/98)
Chern Siang Lee, Margaret Ashton-Key, Sergio Cogliatti, et al.
Oncotarget
|
February 3, 2017
Angioimmunoblastic T cell lymphoma: novel molecular insights by mutation profiling
Ming Wang, Shaowei Zhang, Shih-Sung Chuang, et al.
Frontiers in Immunology
|
February 25, 2021
Developing a 3D B Cell Lymphoma Culture System to Model Antibody Therapy
Russell Foxall, Priyanka Narang, Bridget Glaysher, et al.
Exploration of Targeted Anti-Tumor Therapy
|
September 16, 2024
The genomic and molecular landscape of splenic marginal zone lymphoma, biological and clinical implications
Amatta Mirandari, Helen Parker, Margaret Ashton-Key, et al.
Page
of 4